期刊文献+

恶性肿瘤的三氧治疗 被引量:7

Treatment for malignant tumors with medical Ozone
下载PDF
导出
摘要 三氧(O_3)是由三个氧原子构成的强氧化活性气体,几乎能与任何生物组织反应。医用三氧技术采用血液疗法和直肠灌注疗法,治疗安全可靠。三氧可激活红细胞代谢,增加ATP、2,3二磷酸甘油酸的含量,改善循环,促进组织供氧;激活免疫活性细胞,生成多种免疫活性因子;激活人体的抗氧化酶系统,清除氧化自由基。医用三氧技术在肿瘤放、化疗过程中的应用,能为瘤体内乏氧细胞的再氧合提供新的途径,能有效地改善肿瘤组织供氧,增加肿瘤对化疗和放疗的敏感性;同时还能提高人体免疫力,减轻放疗、化疗对细胞免疫的抑制,清除氧化自由基,消灭残留的肿瘤细胞,减少复发。 Ozone ( O3 ) is a kind of strong oxidized active gas, composed by three oxygen atoms, which can respond nearly with any biological issues. Medical Ozone technology adopts hemotherapy and rectum irrigation therapy and it is safe and reliable. In the human body, Ozone can activate the red blood cell metabolism, increases ATP, the 2,3 - DPG content, improve the circulation, promote the organization to supply the oxygen, activate immune competent cell and the antioxidase system of the body, produce many kinds of immunity active factors and eliminate the oxidized free radical. In the course of chemotherapy and radiotherapy, medical Ozone technology can provide a new way for the oxygen - deficiency cells to gather oxygen again in the tumors, improve the oxygen supply effectively for the tumor tissues, increase the sensitivity of tumors to chemotherapy and radiotherapy, enhance the human body immunity simultaneously, reduce the depression to the cellular immunity of radiotherapy and chemotherapy, eliminates the recrudescence of oxidized free radical and residual tumor cell.
出处 《中国医学创新》 CAS 2010年第30期185-187,共3页 Medical Innovation of China
关键词 肿瘤 三氧 乏氧细胞 细胞免疫 自由基 Tumor Ozone Oxygen - deficiency cell Cellular immunity Free radica
  • 相关文献

参考文献18

  • 1Brown JM.Tumor microenvironment and the response to anticancer thera-py.Concer Biol ther,2002,1(5):453.
  • 2Mahoney BP,Raghunand N,Baggett B,et al.Tumor acidity ion trapping and chemotherapeutics.I.Acid pH affects the distribution of chemotherapeutic agents in vitro.Biochem Pharmacol,2003,66(7):1207.
  • 3Gardner LB,Li Q,Park MS,et al.Hypoxia inhihits GI/S transitiont hrough regulation of p27 expression.J Biol Chem,2001,276(11):7919.
  • 4Toma Dasu I,Dasu A,Karlsson M.The relationship between temporal variation of hypoxia,polarographic measurements and predictions of tumour response to radiation.Phys Med Biol,2004,49(19):463-475.
  • 5Heckel M,schlenger K,Mitze M,et al.Hypoxia and radiation response in human tumors.Semin in Radiat Oncol,1996,6:3-9.
  • 6Gomicki A,Gutsze A.In vitro effects of ozone on human erythrocyte membranes:an EPR study.Acta Biochim Pol,2000,47(4):963.
  • 7Bocci V,Aldinucci C.Rational bases for using oxygen 0zone therapy as a biological response modifier in sickle cellanemia and beta thalassemia:a therapeutic perspective.J Biol Regul Homeost Agents,2004,18(1):38.
  • 8Naumann RW.The role of radiation therapy in early endometrial cancer.J Curr Opin Obstet Gynecol,2002,14(1):75-79.
  • 9Garaci E,Pica F,Sinibaldi-Vallebona P,et al.Thymosinal incombination with cytokines and chemotherapy for the treatment of cancer.Int Immunopharmacol,2003,3(8):1145-1150.
  • 10Bocci V,Larini A,Micheli V.Restoration of normoxia by Ozone therapy may control neoplastic growth:a review and a working hypothesis.J Altem Complement Med,2005,11(2):257-265.

二级参考文献43

  • 1Viebahn R: The biochemical process underlying ozone therapy [ J]. OzoNachrichten, 1985,4 ( 4 ) : 18 - 30.
  • 2Bocci V. Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leukocytes [ J ]. Haematologica, 1990,75(6) :510 -515.
  • 3Bocci V. Ozone as a bioregulator: Pharmacology and toxicology of ozonetherapy today[ J]. J Biol Regul Homeost Agents, 1996,10 (23) : 31 -53.
  • 4Larini A,Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells [ J ]. Toxicol In Vitro, 2005,19 ( 1 ) :55 - 61.
  • 5Peralta C, Bulbena O, Xaus C. Ischemic preconditioning: adefense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion [ J ]. Transplantation,2002,73 ( 8 ) : 1203.
  • 6Wang HM,Smith KA.The interleukin 2 receptor [J].Exp Med,1987;166:1055-1069.
  • 7Glick RP,Lichtor T,Panchal R,et al.Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors [J].J Neurooncol,2003;64(1-2):139-146.
  • 8Zielinski CC,Budinsky AC,Wagner TM,et al.Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in RBCA1 mutations carriers[J].Breast Cancer Res Treat,2003;81(2):99-105.
  • 9Shau H,Gupta RK,Golub SH.Identification of a natural killer enhancing factor (NKEF) from human erythroid cells[J].Cell Immunol,1993;147(1):1-11.
  • 10Eapen CE,Madesh M,Balasubra KA,et al.Mucosal mitochondrial function and antioxidation defenses in patients with gastric carcinoma[J].Sc Gastroenterol,1998;33:975-981.

共引文献48

同被引文献80

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部